T1	SNP 16 32	genetic variants
T2	Entity 37 41	male
R1	Population_assignment Arg1:T1 Arg2:T2	
T3	Cancer 42 55	breast cancer
T4	Association 56 60	risk
E1	Association:T4 bc:T3 snp_int:T1
T5	Entity 64 71	8q24.21
T6	Entity 73 79	9p21.3
T7	Entity 81 88	11q13.3
T8	Entity 93 100	14q24.1
T9	Entity 138 143	Italy
R2	Population_assignment Arg1:T1 Arg2:T9	
R3	SNP_location Arg1:T1 Arg2:T5	
R4	SNP_location Arg1:T1 Arg2:T6	
R5	SNP_location Arg1:T1 Arg2:T7	
R6	SNP_location Arg1:T1 Arg2:T8	
T10	Spec 157 165	evidence
T11	SNP 188 204	genetic variants
A1	SNP_Class T11 Common_variant
T12	Association 209 219	contribute
E2	Association:T12 bc:T13 snp_int:T11
T13	Cancer 245 258	breast cancer
A2	Cancer_Type T13 Hereditary
T14	Cancer 260 262	BC
R7	Equiv Arg1:T14 Arg2:T13	
A3	Cancer_Type T14 Hereditary
R8	Speculation_marker Arg1:E2 Arg2:T10	
T15	Spec 454 457	may
T16	SNP 304 335	single nucleotide polymorphisms
T17	SNP 337 341	SNPs
R9	Equiv Arg1:T17 Arg2:T16	
T18	Entity 355 362	8q24.21
R10	SNP_location Arg1:T17 Arg2:T18	
T19	Association 458 467	influence
E3	Association:T19 bc:T20 snp_int:T16
T20	Cancer 480 482	BC
T21	Entity 486 489	men
R11	Speculation_marker Arg1:E3 Arg2:T15	
R12	Population_assignment Arg1:T16 Arg2:T21	
T22	Entity 409 427	BC-associated loci
R13	SNP_location Arg1:T17 Arg2:T22	
T23	Level 975 986	significant
T24	Association 987 998	association
E4	Association:T24 bc:T25 snp_int:T33
R14	Level_marker Arg1:E4 Arg2:T23	
T25	Cancer 1005 1007	BC
A4	Level E4 High
T26	SNP 1028 1037	rs1562430
T27	SNP 1052 1060	rs445114
T28	SNP 1103 1112	rs1011970
T29	SNP 1131 1139	rs614367
T30	SNP 1162 1171	rs1314913
T31	Entity 1172 1179	14q24.1
R15	SNP_location Arg1:T30 Arg2:T31	
T32	Entity 1087 1094	8q24.21
R16	SNP_location Arg1:T26 Arg2:T32	
R17	SNP_location Arg1:T27 Arg2:T32	
T33	SNP 1017 1026	five SNPs
R18	Member Arg1:T33 Arg2:T26	
R19	Member Arg1:T33 Arg2:T27	
R20	Member Arg1:T33 Arg2:T28	
R21	Member Arg1:T33 Arg2:T29	
R22	Member Arg1:T33 Arg2:T30	
T34	Entity 1113 1119	9p21.3
R23	SNP_location Arg1:T28 Arg2:T34	
T35	Entity 1140 1147	11q13.3
R24	SNP_location Arg1:T29 Arg2:T35	
R25	Population_assignment Arg1:T33 Arg2:T42	
T36	Entity 622 629	Italian
R26	Population_assignment Arg1:T33 Arg2:T36	
T37	SNP 1445 1454	rs1011970
T38	Entity 1455 1461	9p21.3
R27	SNP_location Arg1:T37 Arg2:T38	
T39	Association 1430 1441	Association
E5	Association:T39 snp_int:T37 bc:T41
T40	Entity 1462 1475	risk genotype
R28	Genotype Arg1:T37 Arg2:T40	
T41	Cancer 1481 1486;1487 1489	HER2+ BC
A5	Cancer_Type T41 HER2+
T42	Entity 765 769	male
R29	Population_assignment Arg1:T37 Arg2:T42	
R30	Population_assignment Arg1:T37 Arg2:T36	
T43	SNP 1227 1235	rs614367
T44	Entity 1236 1243	11q13.3
R31	SNP_location Arg1:T43 Arg2:T44	
R32	Equiv Arg1:T43 Arg2:T29	
T45	Association 1192 1203;1211 1223	Differences distribution
E6	Association:T45 snp_int:T43 bc:T46
T46	Cancer 1267 1285;1291 1297	oestrogen receptor status
A6	Cancer_Type T46 Molec_Status_other
T47	SNP 1316 1325	rs1011970
T48	Entity 1326 1332	9p21.3
R33	SNP_location Arg1:T47 Arg2:T48	
T49	Entity 1356 1396	human epidermal growth factor receptor 2
T50	Entity 1398 1402	HER2
R34	Equiv Arg1:T50 Arg2:T49	
T51	Cancer 1398 1402;1404 1410	HER2 status
A7	Cancer_Type T51 Molec_Status_other
T52	Association 1192 1203;1211 1223	Differences distribution
E7	Association:T52 snp_int:T47 bc:T51
R35	Equiv Arg1:T47 Arg2:T28	
T53	SNP 1532 1541	rs1314913
T54	Entity 1542 1549	14q24.1
R36	SNP_location Arg1:T53 Arg2:T54	
T55	Association 1584 1588	risk
E8	Association:T55 snp_int:T53 bc:T57
A8	Effect_Type E8 Increase
T56	Effect_Type 1570 1579	increased
R37	Effect_type_marker Arg1:E8 Arg2:T56	
T57	Cancer 1581 1583	BC
T58	Entity 1615 1619	male
R38	Population_assignment Arg1:T53 Arg2:T58	
R39	Population_assignment Arg1:T53 Arg2:T36	
T59	Entity 1620 1625;1628 1636	BRCA1 mutation
T60	Entity 1620 1624;1626 1636	BRCA 2 mutation
R40	Risk_Factor Arg1:T53 Arg2:T60	
R41	Risk_Factor Arg1:T53 Arg2:T59	
T61	SNP 1793 1802	rs1562430
T62	Entity 1803 1810	8q24.21
R42	SNP_location Arg1:T61 Arg2:T62	
T63	SNP 1815 1824	rs1314913
T64	Entity 1825 1832	14q24.1
R43	SNP_location Arg1:T63 Arg2:T64	
T65	Level 1833 1841	strongly
T66	Association 1842 1851	influence
E9	Association:T66 snp_int:T63 snp_int2:T61 bc:T67
A9	Level E9 High
R44	Level_marker Arg1:E9 Arg2:T65	
T67	Cancer 1852 1854	BC
T68	Entity 1863 1866	men
R45	Population_assignment Arg1:T63 Arg2:T68	
R46	Population_assignment Arg1:T61 Arg2:T68	
R47	Equiv Arg1:T61 Arg2:T26	
R48	Equiv Arg1:T63 Arg2:T30	
T69	Spec 1871 1880	suggested
T70	SNP 1894 1903	rs1314913
T71	Entity 1904 1911	14q24.1
R49	SNP_location Arg1:T70 Arg2:T71	
T72	Spec 1912 1915	may
R50	Equiv Arg1:T70 Arg2:T53	
T73	Association 1925 1938	risk modifier
E10	Association:T73 snp_int:T70 bc:T57
T74	Entity 1948 1952	male
R51	Population_assignment Arg1:T70 Arg2:T74	
R52	Speculation_marker Arg1:E10 Arg2:T72	
T75	Entity 1953 1958;1961 1969	BRCA1 mutation
T76	Entity 1953 1957;1959 1969	BRCA 2 mutation
R53	Risk_Factor Arg1:T70 Arg2:T76	
R54	Risk_Factor Arg1:T70 Arg2:T75	
